ALFAPROT イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

alfaprot

farma gas- medical and technical gases srl - protossido d'azoto - protossido d'azoto

Soliris 300 mg/30 ml Concentrato per soluzione per Infusione スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

soliris 300 mg/30 ml concentrato per soluzione per infusione

alexion pharma gmbh - eculizumabum - concentrato per soluzione per infusione - eculizumabum 300 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 30 ml corresp. natrium 115 mg. - paroxysmale nächtliche hämoglobinurie. atypisches hämolytisch-urämisches syndrom. refraktäre generalisierte myasthenia gravis.; behandlung erwachsener mit neuromyelitis-optica-spektrumerkrankungen (nmosd) - biotechnologika

Ultomiris 300 mg/30 ml Concentrato per soluzione per Infusione スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

ultomiris 300 mg/30 ml concentrato per soluzione per infusione

alexion pharma gmbh - ravulizumabum - concentrato per soluzione per infusione - ravulizumabum 300 mg, natrii dihydrogenophosphas, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 30 ml corresp. natrium 115 mg. - paroxysmale nächtliche hämoglobinurie (pnh); atypisches hämolytisch-urämisches syndrom (ahus); generalisierte myasthenia gravis, neuromyelitis-optica-spektrum-erkrankungen (nmosd) - biotechnologika

Elzonris 欧州連合 - イタリア語 - EMA (European Medicines Agency)

elzonris

stemline therapeutics b.v. - tagraxofusp - lymphoma - agenti antineoplastici - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).

Nexpovio 欧州連合 - イタリア語 - EMA (European Medicines Agency)

nexpovio

stemline therapeutics b.v. - selinexor - mieloma multiplo - agenti antineoplastici - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.

Ultomiris 300 mg/3 ml Concentrato per soluzione per Infusione スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

ultomiris 300 mg/3 ml concentrato per soluzione per infusione

alexion pharma gmbh - ravulizumabum - concentrato per soluzione per infusione - ravulizumabum 300 mg, natrii dihydrogenophosphas, dinatrii phosphas, argininum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 4.6 mg. - paroxysmale nächtliche hämoglobinurie (pnh); atypisches hämolytisch-urämisches syndrom (ahus); generalisierte myasthenia gravis, neuromyelitis-optica-spektrum-erkrankungen (nmosd) - biotechnologika

Ultomiris 1100 mg/11 ml Concentrato per soluzione per Infusione スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

ultomiris 1100 mg/11 ml concentrato per soluzione per infusione

alexion pharma gmbh - ravulizumabum - concentrato per soluzione per infusione - ravulizumabum 1100 mg, natrii dihydrogenophosphas, dinatrii phosphas, argininum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 11 ml corresp. natrium 16.8 mg. - paroxysmale nächtliche hämoglobinurie (pnh); atypisches hämolytisch-urämisches syndrom (ahus); generalisierte myasthenia gravis, neuromyelitis-optica-spektrum-erkrankungen (nmosd) - biotechnologika

Orserdu 欧州連合 - イタリア語 - EMA (European Medicines Agency)

orserdu

stemline therapeutics b.v. - elacestrant - neoplasie al seno - terapia endocrina - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.

SOLUZIONE POLISALINICA CONCENTRATA SENZA POTASSIO S.A.L.F. イタリア - イタリア語 - AIFA (Agenzia Italiana del Farmaco)

soluzione polisalinica concentrata senza potassio s.a.l.f.

s.a.l.f. spa laboratorio farmacologico - associazioni di elettroliti - associazioni di elettroliti

Calcimagon-D3 Compresse masticabili al sapore di limone スイス - イタリア語 - Swissmedic (Swiss Agency for Therapeutic Products)

calcimagon-d3 compresse masticabili al sapore di limone

cps cito pharma services gmbh - cholecalciferolum, calcio - compresse masticabili al sapore di limone - vitamina: cholecalciferolum 400 u. i. di minerali: calcio carbonas 1250 mg corrisp. calcio 500 mg, altro: sono, excipiens pro compresso. - di calcio e di vitamina d integratore - synthetika